Ceska rafinerska, a.s.-石油・ガス分野:企業M&A・提携分析

◆英語タイトル:Ceska rafinerska, a.s. - Oil & Gas - Deals and Alliances Profile
◆商品コード:DATA8012693
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月8日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ceska rafinerska, a.s. (Ceska rafinerska) is a crude oil refining company. It carries out the refining of crude oil, and production of petroleum based products. The company’s product portfolio includes automobile gasoline, diesel oil, aviation fuel, fuel oils, liquefied petroleum gas, heating oil, asphalt and asphalt products, oil hydrogenates, sulphur and raw materials for the petrochemical products. Ceska rafinerska operates refineries in Litvinov and Kralupy nad Vltavou. The company is one of the largest producers of oil products in the Czech Republic. It sells products in domestic market and internationally. It is a member of the Unipetrol Group. Ceska rafinerska is headquartered in Litvnov, Czech Republic.

Ceska rafinerska, a.s. – Oil & Gas – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Oil & Gas eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ceska rafinerska, a.s., Oil & Gas, Deals By Year, 2011 to YTD 2017 5
Ceska rafinerska, a.s., Oil & Gas Deals By Type, 2011 to YTD 2017 6
Ceska rafinerska, a.s., Oil & Gas, Deals By Region, 2011 to YTD 2017 7
Ceska rafinerska, a.s., Oil & Gas, Deals By Sector, 2011 to YTD 2017 8
Ceska rafinerska, a.s., Oil & Gas, Deals Summary, 2011 to YTD 2017 9
Ceska rafinerska, a.s., Oil & Gas, Deal Details 10
Acquisition 10
Unipetrol Completes Acquisition Of Remaining 32.445% Interest In Ceska Rafinerska From Eni For US$26.4 Million 10
Unipetrol Completes Acquisition Of 16.335% Stake In Ceska Rafinerska From Shell Overseas Investments For US$27.2 Million 11
Cepro Plans To Acquire Ceska rafinerska 13
Ceska rafinerska, a.s. – Key Competitors 14
Ceska rafinerska, a.s. – Key Employees 15
Ceska rafinerska, a.s. – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Jan 04, 2017: Unipetrol Completed The Integration Of Ceska rafinerska 17
New Contracts Announcements 18
Jan 04, 2016: UNIPETROL: Ceska Rafinerska Agreed On Oil Storage And Transportation Conditions With MERO 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Ceska rafinerska, a.s., Oil & Gas, Key Facts, 2015 2
Ceska rafinerska, a.s., Oil & Gas, Deals Summary, 2011 to YTD 2017 2
Ceska rafinerska, a.s., Oil & Gas, Deals By Year, 2011 to YTD 2017 5
Ceska rafinerska, a.s., Oil & Gas Deals By Type, 2011 to YTD 2017 6
Ceska rafinerska, a.s., Oil & Gas, Deals By Region, 2011 to YTD 2017 7
Ceska rafinerska, a.s., Deals By Sector, 2011 to YTD 2017 8
Ceska rafinerska, a.s., Oil & Gas, Deals Summary, 2011 to YTD 2017 9
Unipetrol Completes Acquisition Of Remaining 32.445% Interest In Ceska Rafinerska From Eni For US$26.4 Million 10
Unipetrol Completes Acquisition Of 16.335% Stake In Ceska Rafinerska From Shell Overseas Investments For US$27.2 Million 11
Cepro Plans To Acquire Ceska rafinerska 13
Ceska rafinerska, a.s., Key Competitors 14
Ceska rafinerska, a.s., Key Employees 15
Ceska rafinerska, a.s., Other Locations 16

★海外企業調査レポート[Ceska rafinerska, a.s.-石油・ガス分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • Amneal Pharmaceuticals Inc (AMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in the therapeutic areas of analgesic, antibiotic, …
  • Ricoh Leasing Company, Ltd.:戦略・SWOT・企業財務分析
    Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sartorius AG (SRT):企業の財務・戦略的SWOT分析
    Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dining Street Ltd:企業の戦略・SWOT・財務分析
    Dining Street Ltd - Strategy, SWOT and Corporate Finance Report Summary Dining Street Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Rackspace Hosting, Inc.:企業の戦略・SWOT・財務情報
    Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • NuStar GP Holdings LLC (NSH):企業の財務・戦略的SWOT分析
    Summary NuStar GP Holdings LLC (NuStar) is an oil and gas company that offers transportation and logistics services to petroleum products and anhydrous ammonia. The company offers services such as terminalling and storage of petroleum products, petroleum refining and marketing, and transportation of …
  • ROSEN Swiss AG:企業の戦略的SWOT分析
    ROSEN Swiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Mountainview Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Mountainview Energy Ltd (MEL) is an oil and gas exploration and development company. The company explores, produces and develops oil and gas properties in eastern Montana and western North Dakota. It drills and explores oil and gas in the Williston Basin Bakken or Three Forks play and the So …
  • Eastman Kodak Company:戦略・SWOT・企業財務分析
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SpectraCure AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SpectraCure AB (SpectraCure) is a provider of cancer treatment solutions that offers medical device systems containing laser light sources and photoreactive drugs. The company develops and therapy system, commercializes photodynamic with IDOSE for tumors. It provides IDOSE platform which all …
  • HTG Molecular Diagnostics Inc (HTGM):医療機器:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Venture Lighting International Inc:企業の戦略的SWOT分析
    Venture Lighting International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Biomatlante SA:企業の製品パイプライン分析
    Summary Biomatlante SA (Biomatlante) operates as a biologics solutions provider that manufactures, develops, and commercializes synthetic bone graft technologies and synthetic biomaterials for bone regeneration. The company’s products include inserts, granules, sticks, wedges, syringes, putty, screw …
  • Riot Blockchain Inc (RIOT):企業の財務・戦略的SWOT分析
    Riot Blockchain Inc (RIOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Apache Corp (APA):企業の財務・戦略的SWOT分析
    Apache Corp (APA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Brenntag AG:企業のM&A・事業提携・投資動向
    Brenntag AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brenntag AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Alnylam Pharmaceuticals Inc (ALNY):製薬・医療:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆